tiprankstipranks
Elicera Therapeutics AB (SE:ELIC)
:ELIC
Sweden Market
Want to see SE:ELIC full AI Analyst Report?

Elicera Therapeutics AB (ELIC) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Elicera Therapeutics AB’s (ELIC) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Elicera Therapeutics AB is a Sell.
Elicera Therapeutics AB’s (ELIC) 20-Day exponential moving average is 2.74, while Elicera Therapeutics AB’s (ELIC) share price is kr5.35, making it a Buy.
Elicera Therapeutics AB’s (ELIC) 50-Day exponential moving average is 3.14, while Elicera Therapeutics AB’s (ELIC) share price is kr5.35, making it a Sell.

Elicera Therapeutics AB (ELIC) Pivot Points

Jul 05, 2026, 07:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.49
2.59
2.72
2.82
2.95
3.05
3.18
Fibonacci
2.59
2.67
2.73
2.82
2.90
2.96
3.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elicera Therapeutics AB (ELIC) Moving Averages

Jul 05, 2026, 07:33 AM
Period
Simple
Exponential
MA5
2.71Buy
2.77Buy
MA10
2.69Buy
2.72Buy
MA20
2.64Buy
2.74Buy
MA50
2.90Buy
3.14Sell
MA100
4.15Sell
3.81Sell
MA200
4.92Sell
4.57Sell
Elicera Therapeutics AB’s (ELIC) 10-Day exponential moving average is 2.72, while Elicera Therapeutics AB’s (ELIC) share price is kr5.35, making it a Buy.
Elicera Therapeutics AB’s (ELIC) 100-Day exponential moving average is 3.81, while Elicera Therapeutics AB’s (ELIC) share price is kr5.35, making it a Sell.
Elicera Therapeutics AB’s (ELIC) stock price is kr5.35 and Elicera Therapeutics AB’s (ELIC) 50-day simple moving average is 2.90, creating a Buy signal.
Elicera Therapeutics AB’s (ELIC) stock price is kr5.35 and Elicera Therapeutics AB’s (ELIC) 100-day simple moving average is 4.15, creating a Sell signal.
Elicera Therapeutics AB’s (ELIC) stock price is kr5.35 and Elicera Therapeutics AB’s (ELIC) 200-day simple moving average is 4.92, creating a Sell signal.

Elicera Therapeutics AB (ELIC) Technical Indicators

Jul 05, 2026, 07:33 AM
Name
Value
Implied Action
RSI (14)
54.64
Neutral
STOCH (9,6)
59.67
Neutral
STOCHRSI (14)
64.60
Neutral
MACD (12,26)
-0.08
Sell
ADX (14)
20.56
Neutral
Williams %R
-24.32
Buy
CCI (14)
201.58
Sell
ATR (14)
0.22
-
Ultimate Oscillator
53.29
Neutral
ROC
10.15
Buy
Elicera Therapeutics AB’s (ELIC) Relative Strength Index (RSI) is 54.64, creating a Neutral signal.
Elicera Therapeutics AB’s (ELIC) Trend Strength Indicator (ADX) is 20.56, creating a Neutral signal.
Elicera Therapeutics AB’s (ELIC) Commodity Channel Index (CCI) is 201.58, creating a Sell signal.
Elicera Therapeutics AB’s (ELIC) Price Rate of Change (ROC) is 10.15, creating a Buy signal.

FAQ

Is ELIC a Buy, Hold, or Sell?
Based on ELIC’s technical indicators, ELIC is a Buy.
    What is ELIC’s RSI (14)?
    ELIC’s RSI (14) is 54.64, which suggests ELIC is a Neutral.
      What is ELIC’s MACD?
      ELIC’s MACD is -0.08, which suggests ELIC is a Sell.
        What is ELIC’s 5-day moving average?
        ELIC’s 5-day moving average is 2.71, which suggests ELIC is a Buy.
          What is ELIC’s 20-day moving average?
          ELIC 20-day moving average is 2.64, which suggests ELIC is a Buy.
            What is ELIC’s 50-day moving average?
            ELIC’s 50-day moving average is 2.90, which suggests ELIC is a Buy.
              What is ELIC’s 200-day moving average?
              ELIC’s 200-day moving average is 4.92, which suggests ELIC is a Sell.
                What is ELIC’s Williams % R (14)?
                ELIC’s Williams % R (14) is -24.32, which suggests ELIC is a Buy.
                  What is ELIC’s CCI (14)?
                  ELIC’s CCI (14) is 201.58, which suggests ELIC is a Sell.
                    What is the share price of Elicera Therapeutics AB?